AI-powered fundus cameras have been installed at all Cleveland Clinic Cole Eye Institute locations next to primary care ...

Some hospitals are finding it difficult to scale AI across their enterprise — with this process often complicated by things like inadequate technology infrastructures, varying needs across specialties ...

High blood sugars have long been known to cause eye damage in diabetics. However, new research has found that low blood sugar may also contribute. The good news is that it also identified a way of ...

Eye doctors say GLP-1 drugs for diabetes and weight loss may pose rare vision risks, recommending regular checkups.

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...

Please provide your email address to receive an email when new articles are posted on . Ford Medical will distribute AEYE-DS to U.S. pharmacies and non-acute centers. The system pairs with a retinal ...

Medical experts have urged caution over potential eye-related risks associated with GLP-1 receptor agonists, a class of drugs ...

Proliferative diabetic retinopathy and non-proliferative diabetic retinopathy are stages of diabetic retinopathy. The former is the more severe form that can lead to vision loss. Unmanaged diabetes ...

Specialists can identify subtle changes in the retina before symptoms appear and apply treatments that can slow or stop vision loss. Ophthalmologists specialize in the diagnosis and treatment of ...

Use of empagliflozin (Jardiance) was not linked to a lower risk of incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase-4 (DPP-4) inhibitors among patients with type 2 ...